Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.

http://www.wikidata.org/entity/Q34054198

about

Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease Hybrid PET/MR Imaging and Brain Connectivity A neuroradiologist's guide to arterial spin labeling MRI in clinical practice Energy failure: does it contribute to neurodegeneration?Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.The common dementias: a pictorial review.How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer's disease and other neurological disorders.Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.Clinical applications of arterial spin labeling.Feasibility of simultaneous whole-brain imaging on an integrated PET-MRI system using an enhanced 2-point Dixon attenuation correction method.Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study.Prediction and classification of Alzheimer disease based on quantification of MRI deformation.Head-to-Head Visual Comparison between Brain Perfusion SPECT and Arterial Spin-Labeling MRI with Different Postlabeling Delays in Alzheimer Disease.Advances in arterial spin labelling MRI methods for measuring perfusion and collateral flow.Cerebral perfusion in the predementia stages of Alzheimer's disease.Perfusion shift from white to gray matter may account for processing speed deficits in schizophrenia.A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD.Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease.Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience.Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET Visual Assessment of Brain Perfusion MRI Scans in Dementia: A Pilot Study.Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer's disease patients.Sympathetic Innervation of Cold-Activated Brown and White Fat in Lean Young Adults.Vascular risk factors: a ticking time bomb to Alzheimer's disease.Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.Multimodality Imaging Approach in Alzheimer disease. Part I: Structural MRI, Functional MRI, Diffusion Tensor Imaging and Magnetization Transfer Imaging.Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET.Aberrant pattern of regional cerebral blood flow in Alzheimer's disease: a voxel-wise meta-analysis of arterial spin labeling MR imaging studies.Cerebral blood flow changes in remitted early- and late-onset depression patients.

P2860

Q26744646-F8912DDF-070F-4AFF-801F-EC2C02E8E159 Q26766043-C7A42B51-8928-49C8-9C9A-108874228C4F Q26782504-7E79556A-CC8C-47D0-9E1F-EA79A75B8E33 Q28389950-93F39062-328B-4309-9E4B-3FC5B30C60C1 Q28602247-BE6E29DE-7B70-4BF3-A78F-43104907CA96 Q30363365-80A88D88-7E52-43E0-A2EB-B4FC70452DAF Q30670885-4AF424BA-8E3B-4B68-9033-44FDE98F3016 Q30985703-0B0B3254-FF97-4F84-A40D-6A92F1034FBF Q33691776-B64CF67E-92FB-4BEC-AC3D-B2583A367C8A Q34275490-4FDF5023-AD64-4DE3-9443-AADFC5AF8510 Q34378321-FA482260-71B2-43B5-9C3C-D8CF972C2257 Q34573434-8B7FCB5D-CB5F-4308-9D59-FEB283C2541C Q34817029-B4307BC1-29D8-4E7D-B9D3-93B7E670DBD7 Q36034391-C396FCBB-3669-4295-BF95-05158E6A77B3 Q36213409-297A463D-042A-4BF8-BD89-2C3ECB2D0BF7 Q36298571-621BC251-178D-44D2-B28F-995D32CECC61 Q36390056-E4C52358-69AA-4EA5-ADF8-F2EFEE52EA57 Q36396660-9F8A58DC-765A-410E-9CAA-1DB23E764016 Q36460519-00C1F602-6A87-45BD-92F0-2477AC199C2B Q36466959-FFE8A997-A3F3-4FB4-9002-E268BEBDB9A4 Q36767039-B22E4B40-30E6-46E2-8CE7-C21852501B55 Q37184477-74637960-5A90-46D9-9728-E2D9E64E9668 Q37307486-9347C791-1810-454A-BBB1-E6D529ED0C15 Q37514431-E61C429B-D77C-422E-A855-A713995CF8B4 Q37628346-1BE33606-5A2E-4498-B70F-183FA43E2E6B Q37639685-54AB0925-A5D6-4CD4-8E12-BC69513612C8 Q37654110-7145131B-E0F6-4858-B538-6FE4E7E3782C Q37677982-A1B7D3CE-CD1F-46E4-9567-6771068EB274 Q38857172-C6928ADB-4A1D-4F63-93B4-E4D575C11649 Q40533137-DBD99694-FF03-4EF9-AA0E-D6BEC4DAFFB9 Q40881715-C875D4FD-3B8E-4AAE-A116-A792DCD3E69E Q41284835-F2E21B24-ACAC-4F42-A2FC-658F27588630 Q43095202-57179E3F-83B2-42B6-8E69-EC8172D251DC Q43499916-B48DA1C4-6CA6-48E9-A35A-BF42DA771CCA Q45956072-952FFC17-82F9-4917-B0C1-AF935ECFA67B Q46398713-34B24312-CAC1-4BC5-8363-8209C9BBDF2A Q46721933-AB0812FF-DE85-4CBE-9C84-AEC7F3539B52 Q47096954-D162481B-A2DA-4ECE-A530-10FE90ECD8A2 Q47097755-751BB98F-802A-463F-B2DC-1CE078274DAE Q47161405-CA333036-9B85-4B38-94C4-2B885F1068B2

P2860

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.

http://www.wikidata.org/entity/Q34054198

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@ast

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@en

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@nl

type

label

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@ast

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@en

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@nl

prefLabel

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@ast

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@en

Direct comparison of fluorodeo ...... maging in Alzheimer's disease.

@nl

P1433

Q34054198-6F16B074-B00E-4CC7-B841-A954E9A726BC

P1476

Q34054198-36AFEB92-4A78-4F05-AA13-70C294A12E3B

P2093

Q34054198-248A6C12-5598-4446-A5D7-132DB3D24BF0

Q34054198-29DB79B8-658B-4EB1-BB99-DDF905897455

Q34054198-4B980F04-CFC6-436F-99F4-4B83E1ABF59A

Q34054198-68FCA043-D199-448B-B62A-31C5CEF0D1A6

Q34054198-6CAB26AE-A576-4C3E-98D6-BA4C306A7239

Q34054198-8267C28E-CEEB-4DE8-9FA4-9A71EE9CADA4

Q34054198-90B769CF-BAD9-4324-B985-771D05EFB978

Q34054198-A5610913-434B-438C-830A-C7B06EBC3FDC

Q34054198-E9B4DDA8-228A-4D4E-982B-F09682075A81

Q34054198-FF6B41F1-E0E8-4DAC-992F-D3385CE09FB9

P2860

Q34054198-06A848AF-0275-479C-8375-B52CFED2C2A1

Q34054198-0CF5B2BE-5D44-4099-BA8E-EB98781FD885

Q34054198-2D24FCC1-6573-45F9-9608-C4C4EFE6118B

Q34054198-2ECC381C-4023-432F-8A7B-0A6538A2A5D3

Q34054198-3288E690-52B3-43DE-930C-A2815F270522

Q34054198-38E80442-D793-495F-BA12-059B7954BFDA

Q34054198-4005B5E4-6F4E-4D23-82DC-DF8F55419D05

Q34054198-4DC2EA07-45B8-43B4-A17B-588A6C3DBB6F

Q34054198-4DCF8C8F-2AB2-45BD-910B-22136A5EE01E

Q34054198-7BA9E58E-0B56-49BC-BE0E-ED67723B38EB

P304

Q34054198-153F5F50-18DF-4DCE-B6CF-F13EA8527273

P31

Q34054198-5F1EEEBD-8338-4883-B022-40AF06DFFFBF

P356

Q34054198-E6C957D2-F0EB-45C3-B1FB-64B3DACCEC26

P433

Q34054198-091708DC-FFE7-4937-97BA-5C2CBE7EA15E

P478

Q34054198-F7B3FD84-B539-4A21-B191-4FC4AB35AB02

P50

Q34054198-5827ACA3-E987-4E24-8B8F-DEDC08FC80CD

Q34054198-5B824A2A-C732-4643-BBD5-BCC2603093CE

Q34054198-82A2C760-539E-46E7-B810-EDA754E43B2C

P577

Q34054198-2F83DEF3-669E-4E14-9193-15F32254C949

P5875

Q34054198-5488AA0C-5EA7-48C2-956F-20E7F4D03193

P698

Q34054198-8308C005-D96D-4D20-8658-AFF70C2BEA98

P921

Q34054198-1C95CC50-127A-4A9F-8649-B6A0616A94AD

P932

Q34054198-0D139A04-E048-4F99-9998-18C5201CBA64

P356

J.JALZ.2011.06.003

P1433

Alzheimer's and Dementia

P1476

Direct comparison of fluorodeo ...... imaging in Alzheimer's disease

@en

P2093

Abass Alavi

http://www.w3.org/2001/XMLSchema#string

Daniel Y Kimberg

http://www.w3.org/2001/XMLSchema#string

David A Wolk

http://www.w3.org/2001/XMLSchema#string

Janet S Reddin

http://www.w3.org/2001/XMLSchema#string

John A Detre

http://www.w3.org/2001/XMLSchema#string

Marc Korczykowski

http://www.w3.org/2001/XMLSchema#string

Patricia M Martinez

http://www.w3.org/2001/XMLSchema#string

Per Julin

http://www.w3.org/2001/XMLSchema#string

Steven E Arnold

http://www.w3.org/2001/XMLSchema#string

Yufen Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition

Regional aerobic glycolysis in the human brain

Behind the scenes of functional brain imaging: a historical and physiological perspective

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE).

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Perfusion imaging.

Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging.

Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging

P304

51-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2011.06.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Andrew B. Newberg

P577

2011-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51740864

http://www.w3.org/2001/XMLSchema#string

P698

22018493

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3264701

http://www.w3.org/2001/XMLSchema#string